CMV-linked eye infections ID'd in patients without HIV

March 18, 2013
CMV-linked eye infections ID'd in patients without HIV
Cytomegalovirus-associated posterior uveitis or panuveitis can develop in patients without HIV infection, most of whom have evidence of compromised immune function, according to a study published online March 14 in JAMA Ophthalmology.

(HealthDay)—Cytomegalovirus (CMV)-associated posterior uveitis or panuveitis can develop in patients without HIV infection, most of whom have evidence of compromised immune function, according to a study published online March 14 in JAMA Ophthalmology.

Kessara Pathanapitoon, M.D., Ph.D., from Chiang Mai University in Thailand, and colleagues conducted a retrospective observational study to describe the clinical manifestations and comorbidities of 18 patients (22 eyes) without who have CMV-associated posterior uveitis or panuveitis.

The researchers found that all patients exhibited vitreous inflammation. Ocular features included focal hemorrhagic retinitis and peripheral retinal necrosis; in two eyes there were no focal but vasculitis and vitritis were manifested. In 64 percent of the eyes, inflammatory reactions developed in anterior segments. Seventy-three percent of the eyes had retinal vasculitis, including mostly arteries. Eleven patients were taking immunosuppressive medications; one was diagnosed with non-Hodgkin's lymphoma three months after CMV-linked uveitis onset; one had primary immunodeficiency disorder; two had diabetes; and three had no associated systemic diseases and no evidence of immune deficiency.

"CMV-associated infection of posterior eye segments can develop in patients without HIV infection who have variable degrees of compromised but may also occur in individuals who have no evidence of immune insufficiency," the authors write. "It may be that CMV infection located in posterior eye segments of patients without HIV infection is more frequent and has more variable clinical presentation than previously thought."

Explore further: Test approved to help treat common infection in transplant patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

How a virus might make you diabetic later in life

August 27, 2012

Cytomegalovirus (CMV) is one of the viruses that most infected people carry without ill effects. Once infected you are infected for life and, although it normally is dormant, it can become active again at any point in time. ...

Could probiotics help HIV patients?

January 16, 2013

Antiretroviral (ARV) drugs are the first line therapy for patients with HIV; however, ARV-treated, HIV-infected individuals still have a higher mortality rate than uninfected individuals. During the course of infection, HIV ...

Recommended for you

Zika can harm babies' vision, too

April 18, 2017

(HealthDay)—Although Zika virus is most well-known for the devastating neurological damage it can cause in the womb, a new study reports that some babies infected with Zika also may have lifelong vision impairment.

Scientists grow eye cells to fix corneas

April 17, 2017

A Stanford University research team has created a potentially powerful new way to fix damaged corneas—a major source of vision problems and blindness.

Everyone has different 'bad spots' in their vision

April 10, 2017

The ability to distinguish objects in peripheral vision varies significantly between individuals, finds new research from UCL, Paris Descartes University and Dartmouth College, USA. For example, some people are better at ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.